Prostate cancer (PCa) is a major cause of mortality and morbidity in Western society today.
Current methods for detecting PCa are limited, leaving most early malignancies …

BACKROUND Prostate‐specific membrane antigen (PSMA) remains an attractive target for
imaging and therapeutic applications for prostate cancer. Recent efforts have been made to …

Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is
overexpressed in prostate cancer, including hormone-refractory and metastatic disease. Our …

In the past two decades, extensive efforts have been made to develop agents targeting
prostate-specific membrane antigen (PSMA) for prostate cancer imaging and therapy. To …

Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer, and
small-molecule radiopharmaceuticals targeting PSMA rapidly detect the location and extent …

The high mortality and financial burden associated with prostate cancer can be partly
attributed to a lack of sensitive screening methods for detection and staging of the disease …

Prostate-specific membrane antigen (PSMA) is a well-established target for nuclear imaging
and therapy of prostate cancer (PCa). Radiolabeled small-molecule PSMA inhibitors are …

BACKGROUND Prostate specific membrane antigen (PSMA) is overexpressed in prostate
cancer and in tumor vasculature. Small molecule based inhibitors of PSMA have promised …

Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …

Prostate cancer (PC) is the prevalent malignancy widespread among men in the Western
World. Prostate specific membrane antigen (PSMA) is an established PC marker and has …